✦ LIBER ✦

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study

✍ Scribed by Dediu, M; Horvat, T; Tarlea, A; Nicodin, A; Movanu, M; Radult, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of docetaxel and cisplati

✍ Y. H. Kim; J. S. Kim; Y. H. Choi; K. H. In; H. S. Park; D. S. Hong; T. J. Jeong; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 67 KB

A three-week schedule of gemcitabine plu

✍ M.R. Migliorino; F. Nelli; F. Facciolo; A. Cipri; R. Belli; M.V. Ammaturo; O. Ar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A phase II study of docetaxel (taxotere)

✍ Kim, H.K; Lee, K.S; Kim, J.S; Kim, Y.K; Park, H.S; Chung, T.J; Lee, S.N; Kang, K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Dose-finding study of irinotecan and cis

✍ Yokoyama, A; Kurita, Y; Saijo, N; Tamura, T; Noda, K; Shimokata, K; Matsuda, T 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 1002 KB

PD-086 A phase II randomised study of ge

✍ Brechot, J.; Saintigny, P.; Azorin, J.; Valeyre, D.; Breau, J.; Morere, J.; Gnom 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Doublet regimen of cisplatin plus doceta

✍ Takashi Seto; Yoriko Takezako; Hiroko Nakamura; Kayo Takeda; Fumiko Inoue; Hiros 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 193 KB